BRCA1 and neoplasm: Results on the prognostic value of tumor BRCA1-PM in TNBC patients have been conflicting [26, 61–65], which may be due to different methods to analyze BRCA1-PM status [66, 67], different reference groups (including gBRCA1m patients or not), or different treatments [62, 64].